Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: nab paclitaxel|DRUG: Cyclophosphamide|DRUG: Trastuzumab
Sponsor: SCRI Development Innovations, LLC
Collaborators: Celgene Corporation